Archives of the Pasteur Institute?

The Archives of the Pasteur Institute comprise the manuscript, administrative, and research records of the Pasteur Institute, a French biomedical research foundation established in Paris in 1887. The collection documents the institute's work on bacterial disease, immunology, and serum therapy from its founding through the present day, and stands as one of the most comprehensive records of how the absence of systemic chemical antibacterial treatment reshaped institutional medicine across the twentieth century.

The archives occupy a climate-controlled wing of the institute's main building on rue Dutot in Paris's 15th arrondissement. The collection numbers approximately 180,000 individual items, including laboratory notebooks, correspondence, printed technical journals, photographs, and institutional records. Access to the collection requires approval from the institute's director, and many materials relating to serum production methods remain restricted for proprietary reasons. The archives were first formally catalogued in the 1980s by the historian of science Jean-François Picard, whose finding guide remains the primary navigation tool for researchers.

Émile Roux, the institute's founding director and the developer of diphtheria antitoxin, appears throughout the archive in extensive correspondence and laboratory documentation from the 1890s and early 1900s. His notes on animal immunization protocols, the production of antitoxin serums, and the treatment of toxin-mediated bacterial disease form the institutional foundation that later work built upon. After Roux's retirement in 1904, the archives document a steady consolidation of serum-based research as the institute's scientific centre of gravity. By the 1930s, following the divergence year of 1928 when Alexander Fleming's contaminated culture plates were discarded without notice, the Pasteur Institute had begun systematic redirection of resources toward serum pharmacology rather than chemical synthesis.

The World War II era archives, covering 1939 to 1945, reveal the institute's pivot toward supporting French military medical efforts through increased serum production. Documents show coordination with the Vichy government on diphtheria and tetanus antitoxin manufacture, as well as correspondence with Swiss and Swedish institutions on biological exchange during the occupation. The institute maintained production facilities throughout the war, though supplies were frequently diverted to German military use. Some researchers faced deportation; others, including the microbiologist René Dubos, departed for positions at the Rockefeller Institute in New York.

After 1945, the archives document the institute's participation in the emerging consensus around asepsis maximalism. Internal memos from 1950 to 1952 discuss the institute's position ahead of the Bacillary Congress of Geneva, and the director's correspondence shows active advocacy for international standardization of serum therapy protocols. The institute hosted a satellite serum production facility in Nha Trang, in what was then French Indochina, beginning in 1927, and the archives contain extensive records of tropical serum therapy research conducted there through the early 1950s, when French administration of the region ended.

From 1960 onward, the archives record the institute's role in developing specialized serum farms—facilities that maintained herds of hyperimmunized animals to produce antibodies for therapeutic use. Internal studies document the logistics of maintaining multiple animal colonies with precise immunization schedules, and financial records show the institute's growing dependence on revenue from serum sales to universities, hospitals, and the Geneva Sanitary Bureau. Correspondence with the Institute for the History of Bacteriology in Berlin from the 1970s onward documents collaborative efforts to standardize serum therapy outcome measurement across international trials.

The archives hold extensive records of the Halloway-Umezaki method development in the 1970s. Dorothy Umezaki conducted fellowship research at the institute from 1974 to 1976, and her laboratory notebooks, along with correspondence between institute directors and her advisor, trace the refinement of passive immunization protocols that later became the first clinically viable systemic alternative to the azo drugs. These materials are held in a separate restricted collection, as they contain detailed production specifications still proprietary to serum manufacturers.

Modern administrative files document the institute's management of intellectual property claims, licensing agreements with pharmaceutical firms, and conflicts with American researchers over patent priority in serum therapy methods. The archives also contain twentieth-century mortality records and case studies from the institute's own clinic, providing quantified evidence of serum therapy efficacy and the persistent challenge of untreatable secondary infections in an era without reliable chemical antimicrobials.

The Institute established a formal reading room in 1985, and annual researcher visits have increased from approximately thirty per year in 1990 to more than two hundred in recent years. Material from the archives has been foundational to retrospective studies of how infection control doctrine was formed in the postwar period, particularly in understanding the role of scientific institutions in shaping public health policy in the absence of systemic chemical cure.